Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

AtaiBeckley Inc. - Common Stock (NQ:ATAI)

3.700 -0.020 (-0.54%)

Streaming Delayed Price Updated: 2:04 PM EST, Jan 15, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,560,563
Open	3.730
Bid (Size)	3.700 (3,400)
Ask (Size)	3.710 (6,300)
Prev. Close	3.720
Today's Range	3.680 - 3.780
52wk Range	1.150 - 6.750
Shares Outstanding	166,010,476
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

AtaiBeckley Provides Update and Outlook for 2026 Ahead of J.P. Morgan Healthcare Conference

January 08, 2026

From AtaiBeckley N.V.

Via GlobeNewswire

GH Research Stock Grabs Retail Spotlight Ahead Of FDA Update On Depression Treatment ↗

January 05, 2026

GH001 showed symptom improvement, high remission rates, and sustained benefits in a Phase 2b trial for treatment-resistant depression.

Via Stocktwits

Performance

YTD	-4.4%	-4.4%
1 Month	-10.6%	-10.6%
3 Month	-37.9%	-37.9%
6 Month	+37.0%	+37.0%
1 Year	+178.2%	+178.2%

More News

AtaiBeckley Completes Redomiciliation to the United States

December 30, 2025

From AtaiBeckley N.V.

Via GlobeNewswire

AtaiBeckley Added to the Nasdaq Biotechnology Index (NBI)

December 23, 2025

From AtaiBeckley N.V.

Via GlobeNewswire

MarketBeat’s Top 5 Rated Small-Cap Stocks ↗

December 22, 2025

Via MarketBeat

Optimism Flows From Pot To Psychedelics: Atai Beckley, Supernus Stocks Rise After Analyst Flags Positive Tailwinds From Trump’s Marijuana Order ↗

December 19, 2025

Via Stocktwits

AtaiBeckley Announces New U.S. Patent Granted for EMP-01, Strengthening Intellectual Property Portfolio

December 11, 2025

From AtaiBeckley N.V.

Via GlobeNewswire

AtaiBeckley to Participate in the Jefferies Global Healthcare Conference in London

November 13, 2025

From AtaiBeckley N.V.

Via GlobeNewswire

AtaiBeckley Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights

November 12, 2025

From AtaiBeckley N.V.

Via GlobeNewswire

AtaiBeckley Announces Positive Topline Data from the Phase 2b Open-Label Extension Study of BPL-003, Supporting Safety and Efficacy of a Second Dose in Patients with Treatment-Resistant Depression

November 10, 2025

From AtaiBeckley N.V.

Via GlobeNewswire

atai Life Sciences and Beckley Psytech Announce the Successful Completion of Their Strategic Combination to Create AtaiBeckley, a Global Leader in Transformative Mental Health Therapies

November 05, 2025

From AtaiBeckley N.V.

Via GlobeNewswire

Analyst Expectations For ATAI Life Sciences's Future ↗

October 22, 2025

Via Benzinga

atai Life Sciences Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Common Shares

October 20, 2025

From atai Life Sciences

Via GlobeNewswire

Why Atai Life Sciences Stock Was So Lively This Week ↗

October 17, 2025

Via The Motley Fool

atai Life Sciences Announces Pricing of Public Offering of Common Shares

October 16, 2025

From atai Life Sciences

Via GlobeNewswire

atai Life Sciences Announces Proposed Public Offering of Common Shares

October 16, 2025

From atai Life Sciences

Via GlobeNewswire

atai Life Sciences and Beckley Psytech Announce U.S. FDA Breakthrough Therapy Designation Granted to BPL-003, Underscoring its Potential in Treatment-Resistant Depression

October 16, 2025

From atai Life Sciences

Via GlobeNewswire

Market Momentum: A Diverse Group of Stocks Soar to 52-Week Highs Amidst Shifting Tides

October 14, 2025

Via MarketMinute

Atai Life Sciences Remains Undervalued, Analyst Initiates With Around 125% Stock Upside ↗

October 13, 2025

Via Benzinga

Alibaba, Lithium Americas And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session ↗

September 24, 2025

Via Benzinga

Demystifying ATAI Life Sciences: Insights From 5 Analyst Reviews ↗

September 23, 2025

Via Benzinga

Why Atai Life Sciences Stock Crushed It on Tuesday ↗

September 23, 2025

Via The Motley Fool

Atai Life Sciences Experimental Depression Drug Shows Sustained Benefit In Treatment-Resistant Patients ↗

September 23, 2025

Via Benzinga

atai Life Sciences and Beckley Psytech Report Positive Phase 2a Data Demonstrating Improved Outcomes with a Two-Dose Induction Regimen of BPL-003 in Patients with Treatment-Resistant Depression

September 23, 2025

From atai Life Sciences

Via GlobeNewswire

MissionIRNewsBreaks – Brera Holdings PLC (NASDAQ: BREA) Jumps as ARK Invest Buys $49.7M Stake, Trims Roku and Tempus AI

September 19, 2025

Via Investor Brand Network

Frequently Asked Questions

Is AtaiBeckley Inc. - Common Stock publicly traded?

Yes, AtaiBeckley Inc. - Common Stock is publicly traded.

What exchange does AtaiBeckley Inc. - Common Stock trade on?

AtaiBeckley Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for AtaiBeckley Inc. - Common Stock?

The ticker symbol for AtaiBeckley Inc. - Common Stock is ATAI on the Nasdaq Stock Market

What is the current price of AtaiBeckley Inc. - Common Stock?

The current price of AtaiBeckley Inc. - Common Stock is 3.700

When was AtaiBeckley Inc. - Common Stock last traded?

The last trade of AtaiBeckley Inc. - Common Stock was at 01/15/26 02:04 PM ET

What is the market capitalization of AtaiBeckley Inc. - Common Stock?

The market capitalization of AtaiBeckley Inc. - Common Stock is 614.24M

How many shares of AtaiBeckley Inc. - Common Stock are outstanding?

AtaiBeckley Inc. - Common Stock has 614M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.